Article
International Regulations for Bioequivalence Approval of Locally Acting Orally Inhaled Drug Products
2021-01-09
Abstract excerpt
Bioequivalence (BE) is established between the brand drug and the generic drug to allow the linking of preclinical and clinical testing conducted on the reference listed drug. Regulatory agencies around the globe have come up with the guidance for locally acting orally inhaled drug products (OIDPs) for bioequivalence approaches. The prime intent of the present article is to compare approaches of different internat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bde7f733-37ae-5b82-bee2-975f84781f98
- DOI
- 10.22541/au.161019131.19061881/v1
